Factors Associated With Success of the Extreme Drug Resistance Assay in Primary Breast Cancer Specimens Robert J. EllisCarol J. FabianJohn P. Fruehauf Conference Report Pages: 95 - 102
Breast and Ovarian Cancer Screening Practices in Healthy Women with a Strong Family History of Breast or Ovarian Cancer Claudine IsaacsBeth N. PeshkinCaryn Lerman Conference Report Pages: 103 - 112
Self-Reported Dietary Habits, Overall Dietary Quality and Symptomatology of Breast Cancer Survivors: a Cross-Sectional Examination C.C. TangneyJ.A. YoungD.M. Oleske Conference Report Pages: 113 - 123
Tamoxifen-Induced Increases in Cytoplasmic Free Ca2+ Levels in Human Breast Cancer Cells Hong-Tai ChangJong-Khing HuangChung-Ren Jan Conference Report Pages: 125 - 131
Irofulven Induces Apoptosis in Breast Cancer Cells Regardless of Caspase-3 Status* Maryanne C.S. HerzigHuiyun LiangJan M. Woynarowski Conference Report Pages: 133 - 143
Minor Role for BRCA2 (Exon11) and p53 (Exon 5–9) Among Sudanese Breast Cancer Patients M.A. MasriN.M. Abdel SeedM.E. Ibrahim Conference Report Pages: 145 - 147
In Vitro Cytotoxicity of Bismuth-213 (213bi)-Labeled-Plasminogen Activator Inhibitor Type 2 (Alpha-PAI-2) on Human Breast Cancer Cells M. RansonZ. TianB.J. Allen Conference Report Pages: 149 - 159
Prognostic Significance of Tumor Cell Proliferation Analyzed in Fine Needle Aspirates from Primary Breast Cancer A-M BillgrenE TaniLE Rutqvist Conference Report Pages: 161 - 170
Selective Axillary Surgery in Breast Cancer Patients Based on Positron Emission Tomography with 18F-Fluoro-2-Deoxy-D-Glucose: not Yet! Ulrich GullerEgbert U. NitzscheMarkus Zuber BriefCommunication Pages: 171 - 173